NR3C2 and cardiac hypertrophy: L-NAME-induced increase in mineralocorticoid receptor concentration in the kidney observed in this study was in line with previous reports that indicated that L-NAME treatment activated the renal renin angiotensin system (RAS) [48] while cardiac hypertrophy was also observed in L-NAME treated rats [49].